The estimated Net Worth of Stanley Jr Jacot is at least $14.3 millier dollars as of 30 May 2023. Mr Jacot owns over 5,000 units of Arcadia Biosciences Inc stock worth over $14,300 and over the last 3 years he sold RKDA stock worth over $0.
Mr has made over 1 trades of the Arcadia Biosciences Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of RKDA stock worth $21,550 on 30 May 2023.
The largest trade he's ever made was buying 5,000 units of Arcadia Biosciences Inc stock on 30 May 2023 worth over $21,550. On average, Mr trades about 1,667 units every 0 days since 2022. As of 30 May 2023 he still owns at least 5,000 units of Arcadia Biosciences Inc stock.
You can see the complete history of Mr Jacot stock trades at the bottom of the page.
Stanley E. Jacot Jr. is the Pres, CEO & Director at Arcadia Biosciences Inc.
Mr Jr is 51, he's been the Pres et CEO & Director of Arcadia Biosciences Inc since . There are 6 older and 4 younger executives at Arcadia Biosciences Inc. The oldest executive at Arcadia Biosciences Inc is Donald Emlay, 73, who is the Vice President - Regulatory Affairs and Compliance.
Stanley's mailing address filed with the SEC is C/O ARCADIA BIOSCIENCES, INC., 5950 SHERRY LANE, SUITE 215, DALLAS, TX, 75225.
Over the last 9 years, insiders at Arcadia Biosciences Inc have traded over $35,492 worth of Arcadia Biosciences Inc stock and bought 2,813,834 units worth $22,335,794 . The most active insiders traders include Terri Csperling Peter V Mor..., Darby E Shupp et Albert D. Bolles. On average, Arcadia Biosciences Inc executives and independent directors trade stock every 49 days with the average trade being worth of $147,899. The most recent stock trade was executed by Mark Kawakami on 1 August 2024, trading 700 units of RKDA stock currently worth $1,442.
arcadia biosciences (nasdaq: rkda) develops and markets high-value food ingredients and nutritional oils that help meet consumer demand for a healthier diet. arcadia’s goodwheat™ branded ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. the company’s portfolio of agricultural traits are being developed to enable farmers around the world to be more productive and minimize the impact of agriculture on the environment. for more information visit www.arcadiabio.com.
Arcadia Biosciences Inc executives and other stock owners filed with the SEC include: